These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9742026)
1. Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment. Cannistra LB; Cannistra AJ N Engl J Med; 1998 Sep; 339(11):771. PubMed ID: 9742026 [No Abstract] [Full Text] [Related]
6. Taking things to heart. Hess MA J Am Diet Assoc; 2004 Jul; 104(7):1073; author reply 1073-4. PubMed ID: 15215760 [No Abstract] [Full Text] [Related]
7. Studies confirm link between fen-phen and heart-valve disease. Harv Heart Lett; 1998 Dec; 9(4):4-6. PubMed ID: 9925979 [No Abstract] [Full Text] [Related]
8. Further cases of valvular heart disease associated with fenfluramine-phentermine. Graham DJ; Green L N Engl J Med; 1997 Aug; 337(9):635. PubMed ID: 9280830 [No Abstract] [Full Text] [Related]
10. Valvular heart disease associated with fenfluramine-phentermine. Kurz X; Van Ermen A N Engl J Med; 1997 Dec; 337(24):1772-3; author reply 1775. PubMed ID: 9411247 [No Abstract] [Full Text] [Related]
11. The fen-phen controversy: is regression another piece of the puzzle? Asinger RW Mayo Clin Proc; 1999 Dec; 74(12):1302-4. PubMed ID: 10593359 [No Abstract] [Full Text] [Related]
12. Valvular heart disease associated with fenfluramine-phentermine. Spitzer WO N Engl J Med; 1997 Dec; 337(24):1774-5; author reply 1775-6. PubMed ID: 9411251 [No Abstract] [Full Text] [Related]
13. Longitudinal effects of fenfluramine-phentermine use. Bhattacharyya S; Constantin C; Davar J; Mikhailidis D Angiology; 2007 Dec-2008 Jan; 58(6):772-3; author reply 774. PubMed ID: 18216387 [No Abstract] [Full Text] [Related]